-

Record Month in Hepatocyte Sales Advances TRL’s Reputation as the World’s Fastest-Growing Hepatocyte Provider | Nearly One Million Dollars Sold Makes June TRL’s Most Profitable Month Ever

RESEARCH TRIANGLE PARK, N.C.-July 13, 2015 – After reaching a record high in sales for 2014, the biotechnology company, Triangle Research Labs (TRL), knocked earnings expectations out of the park and had their most profitable month ever in June. The LLC attributes last month’s success to favorable relationships with pharma, clinical research, academia, and government professionals.

 

Human Cryopreserved hepatocytes accounted for 80 percent of June’s profits, which  Matt Sherman, Executive Director of TRL, believes is directly linked to the product’s reputation in the industry. “Our lots are held to the highest quality standards, both quantitatively and qualitatively,” said Sherman.  “Induction lots are characterized for mRNA expression and specific activity, to ensure they meet regulatory and industry standards for fold CYP induction. Our strategy is to provide the highest quality hepatocytes with a high level of service and support and accessible pricing.”

 

The strategy identified by Sherman appears to be working. TRL is on track to significantly increase 2014’s total sales by the end of this year. The company plans to propel its success by refining its digital strategy and continuing to develop the efficiency of its laboratory. “My goal for the Operations Team is to produce our high-quality hepatic products as efficiently as possible,” said Rob Kaiser, Director of Operations. “We currently have 2 full-time Production Scientists, Bethany Mextorf and Sarah El-Halabi, and a full-time Lab Manager, Maggie McIntyre.  I don’t foresee the team growing much larger than that.  Keeping the team small minimizes overhead, which allows us to pass those savings along to our clients,” said Kaiser.

 

Since its launch in 2012, TRL has quickly made a name for itself in the biotechnology industry.  Located in Research Triangle Park, NC, the company is consistently recognized as one of the top hepatocyte vendors in the world.

 

About TRL, LLC

Triangle Research Labs, LLC (TRL), produces high-quality hepatocytes for use in pre-clinical ADMETox applications. We provide both human and animal, fresh and cryopreserved hepatocytes, and their relevant media. Additionally, TRL distributes –cryopreserved NoSpin HepaRG™ products for Biopredic International. A leader in quality and service, TRL’s expert staff has decades of experience in the hepatic sciences.

 

Our mission is to assist in the discovery and development of meaningful therapeutic agents that benefit the human condition. We are committed to providing the highest quality products that consistently exceed customer expectations. We build lasting relationships, understanding each customer’s specific needs and work mutually towards the common goal of improving the quality of life.

Visit www.triangleresearchlabs.net, for More Information.

We offer great discounts on bulk orders of cryopreserved hepatocytes. Contact us for more information.